Share Name Share Symbol Market Type Share ISIN Share Description
Science Group Plc LSE:SAG London Ordinary Share GB00B39GTJ17 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 240.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
230.00 250.00 240.00 240.00 240.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 57.25 -1.61 -4.50 99
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 240.00 GBX

Science (SAG) Latest News

More Science News
Science Takeover Rumours

Science (SAG) Discussions and Chat

Science Forums and Chat

Date Time Title Posts
23/9/202013:28SCIENCE GROUP106
24/7/201807:48Science Group (SAG) One to Watch on Monday 2
21/4/201716:40SAGENTIA PLC600
19/1/201710:15Shareholder Action Groups4

Add a New Thread

Science (SAG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Science trades in real-time

Science (SAG) Top Chat Posts

Science Daily Update: Science Group Plc is listed in the Support Services sector of the London Stock Exchange with ticker SAG. The last closing price for Science was 240p.
Science Group Plc has a 4 week average price of 240p and a 12 week average price of 235p.
The 1 year high share price is 258p while the 1 year low share price is currently 165p.
There are currently 41,132,229 shares in issue and the average daily traded volume is 7,585 shares. The market capitalisation of Science Group Plc is £98,717,349.60.
varies: Having held shares in Microgen (now Aptitude)for many years, I have high regard for Mr Martyn Ratcliffe, the chairman and a major shareholder here. He left Microgen in 2015. It seems that the directors have decided after their review (and in the absence of an attractive outside offer for SAG) to embark on a new venture with this takeover of FST. They have the resources needed to develop the DAB business which FST was plainly unable to raise. I have bought what is for me quite a large holding in SAG in the hope that they can make a success of this. The share price has settled for some time at about 200p and this thread appears dormant. There is scope for a little excitement when the FST transaction is completed and SAG tell us more of their plans.
truffle: It seems from last year's annual statement that over 50% of group revenue comes in the form of US dollars and euros which might explain the recent rapid recovery in the share price
jombaston: The latest buy looks good although some uncertainty as all the numbers quoted are from 2013 (Leatherhead didn't manage to file their 2014 accounts!) Clearly the pension fund at Leatherhead was a serious burden and the firm had quite high costs given its revenue. SAG will be putting up another £1m investment along with the £1.6m purchase price but even including this the payback should be pretty quick. Replicating SAG's margins would imply £1.5m pre-tax; while this is not going to happen overnight £750k should be achievable near-term (they made £670k in 2012). Taking this into account and using SAG EV/EBIT multiples before the deal I reckon this should be worth a share price of 170-185p for SAG. This, of course, assumes the shares were fairly priced beforehand. Arguably they were cheap, so I believe a target of £2 is fair absent any further news. Please feel free to disagree or embellish! DYOR etc
battlebus2: Great news this morning with an acquistion with cash and treasury shares, also the proposed return via tender would not recieve support at the current share price but other plans will be released with results on 3rd of March. Special dividend?? Either way its good news to me and surely ends talk of delisting and allows the shares to continue their upwards trajectory.
anumidium: Agree Oregano, a decent divi would help underwrite the share price.
oregano: not alot of detail but scant comment elsewhere. Sagentia, the AIM-listed, Cambridge-headquartered multidiscipline R&D outsourcing firm chaired by Martyn Ratcliffe, seems to have got itself back on track in the second half of the year after a major US project was suspended in H1 (see here). Although the company returned to growth in H2, this was not enough to mitigate the revenue loss, leaving headline revenues for the year to 31st Dec. 6% down at £22.3m. Operating profit fell more sharply, by 11%, to £3.2m, shaving nearly a point off margins, to 14.5%. However, carried-forward tax losses left EPS 3% higher at 7.5p. Ratcliffe, should have more time to devote to Sagentia after he steps down as chairman of UK education software and IT services firm, RM (see RM enters next phase as Ratcliffe exits). He remains long-time chairman at Microgen. Despite the share price dip earlier in the year, Sagentia's shares are back trading over 95p, 13% higher than 12 months ago. The company also announced a maiden 1p a share div.
abadan2: Cestnous, I think you have missed the point. The company was offering to buy shares from any of the existing holders (institutions or PIs), by definition on terms that were beneficial to the company and continuing shareholders. This would have given any big shareholders who wanted to sell the chance to get out, and would have removed any overhang of shares. It is clear that harly anyone wants to sell at 80p beliving that the shares should be a lot higher, hence the jump in the share price on the annoucement.
cfro: 'tis a very funny time of the day to release a trading statement. Why no share price reaction? Well, apart from a lot of investors missing it, i would say the word 'slightly' ahead instead of 'significantly' ahead perhaps has disappointed some. If its only going to be the 'slighty' ahead then slightly ahead of what?....7.4p ??......then if so can we expect 8p eps? But nevertheless, even suggestiong eps of 8p would still put the share price on a PE of 11 which is still too cheap imo. What interests me most tho, is all that cash. The co could pay us shareholders out say, 10% of that and still retain a decent amount.
hastings: Some interesting comments from some sound posters here. Must say, didn't get involved when the share price was in the doldrums, past record wasn't good and rather a complex structure of the business too. However, have to agree with you guys here in that SAG looks excellent value at these levels. Both on Fundamentals and the new direction that has been adopted. Some interesting bits below, that may or may not have been posted before, so apologies now if i am merely running a repeat! One question though, does any holder know what SAG's remaining and diluted holding is in Sphere.
Science share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200925 11:59:27